Tradestie Institutional Equity Comparison Engine

ACB vs UHGWW โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ACB Overall Edge

ACB Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Aurora Cannabis Inc. Common Shares (ACB) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ACB trades at 109.9x Forward P/E with -13.8% operating margin (-8.8% YoY revenue) versus UHGWW at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ACB sits in CONSOLIDATION (60th %ile IV; Dealer Gamma Walls on Pro) against UHGWW sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ACB
ACB 109.9x vs UHGWW N/M Fwd P/E
Growth & Margin Winner ACB
Op Margin -13.8% vs N/A ยท YoY -8.8% vs N/A
Momentum & Technical Winner ACB
1Y -3.3% vs -69.9% ยท 52W Pos 42% vs 7%
Options & Structure Winner ACB
CONSOLIDATION (60th %ile IV) vs UNCLASSIFIED (N/A IV)
ACB NASDAQ
Aurora Cannabis Inc. Common Shares
Medicinal Chemicals & Botanical Products
$4.16
-2.35% 1D
Market Cap $280.1M
1M Return +4.79%
1Y Return -3.26%
Forward P/E 109.9x
Unified AI Score
44.2 / 100 HOLD
Tech 20.0 Fund 46.0 Flow 61.0 Mom 70.0
UHGWW NASDAQ
United Homes Group, Inc. Warrant
Operative Builders
$0.23
+28.13% 1D
Market Cap N/A
1M Return +37.03%
1Y Return -69.87%
Forward P/E N/M
Unified AI Score
51.6 / 100 HOLD
Tech 60.0 Fund 54.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ACB -3.26% UHGWW -69.87% Spread: +149.71 pp (UHGWW Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ACB TTM Op. Margin: -13.8% UHGWW TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ACB vs UHGWW. Trailing 12-month operating profitability (ACB -13.8% vs UHGWW N/A) and valuation multiples (ACB 109.9x vs UHGWW N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ACB (9) vs UHGWW (1)
Institutional Metric ACB UHGWW Criterion Row Winner
Market Capitalization Scale $280.1M N/A Larger Scale ACB
Trailing P/E Ratio Valuation 109.9x N/M Lower Multiple ACB
Forward P/E Ratio Valuation 109.9x N/M Lower Multiple ACB
Revenue Growth (YoY) Growth -8.8% N/A Higher Growth ACB
Operating Margin (TTM) Profitability -13.8% N/A Higher Margin ACB
Net Profit Margin Profitability -38.2% N/A Higher Margin ACB
Return on Equity (ROE) Capital Efficiency -9.4% N/A Higher ROE ACB
52-Week Range Position Momentum 42% ($3โ€“$6) 7% ($0โ€“$2) Stronger Trend ACB
Beta / 30D Volatility Risk Regime 1.06ฮฒ ยท 88% Vol 1.85ฮฒ ยท 112% Vol Lower Realized Risk ACB
Unified Institutional Score Composite Signal 44.2 / 100 (HOLD) 51.6 / 100 (HOLD) Higher Composite UHGWW

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ACB vs UHGWW Buy Guide
ACB CONSOLIDATION
33d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 60th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live ACB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
UHGWW UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live UHGWW Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ACB nor UHGWW registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.